Doctor Care Anywhere (ASX:DOC) share price jumps 6% on record quarter

It was a record-setting quarter for the telehealth company…

| More on:
A telehealth doctor at her desk.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Doctor Care Anywhere Group PLC (ASX: DOC) share price is finding enthusiasm on Wednesday after releasing its third-quarter trading and activities update. The market has responded positively to the United Kingdom-based telehealth company's record-setting quarter.

At the time of writing, shares in Doctor Care Anywhere are fetching 74.5 cents apiece, an increase of 6.43%. For comparison, the S&P/ASX 200 Index (ASX: XJO) is trading 0.82% higher heading into the afternoon.

Let's peel back the wrapping on this quarterly surprise.

Why is the Doctor Care Anywhere share price surging today?

It was a solid quarter for the telehealth company. While some investors may have expected growth to slow down as a result of the UK's lockdown restrictions ending, it had the opposite effect. To briefly summarise, here are some highlights from the quarter:

  • Revenue increased 21.6% quarter on quarter to A$10.7 million
  • Number of consultations grew by 30.6% quarter on quarter to 116,800
  • Number of signups (or activated lives) reached 603,200
  • Completed the acquisition of Australian telehealth and tele-mental provider, GP2U Telehealth
  • A record 41,000 patients had their first consultation with the company
  • Net operating cash outflows of A$4.24 million compared to A$1.11 million in the prior quarter.

What happened during the quarter?

In its first quarter since UK lockdowns had been lifted, Doctor Care Anywhere witnessed a re-acceleration in growth. This is demonstrated by the significant rise in revenue compared to the prior quarter. For instance, the A$10.7 million derived in Q3 is roughly half the total revenue collected in FY20.

Due to the reopening, wait times for appointments across the UK public health system have deteriorated. This has been a positive for the company, as more patients turn to a more convenient and efficient alternative.

In September alone, 45,800 consultations were handled, with 1,900 patients completing Doctor Care's secondary care diagnostic pathway. The sudden influx in demand looks good for the Doctor Care Anywhere share price.

Illustrating the recurring nature of Doctor Care's telehealth service, more than 65% of consultations were to returning patients. The company aims to scale in response to demand in a bid to increase its pool of returning patients.

Additionally, with the company attempting to capture the increase in demand, operating margins were depressed during Q3. This was as a result of Doctor Care increasing its investment in the supply of clinicians. However, it remains confident that these decisions will eventually lead to better margins in 2022.

While the numbers appeared to be positive for revenue growth, they came at a cost. Consequently, net operating cash outflows increased to A$4.24 million from A$1.11 million in the prior quarter.

Management commentary and outlook

Commenting on the third-quarter result, Doctor Care Anywhere CEO Dr Bayju Thakar said:

We are excited by the continuing rapid growth in demand for our services. The increasing volume of consultations and diagnostic referrals completed in Q3 provides further evidence that patients, doctors and insurers are seeing the benefits of our integrated digital offering.

The convenience that our solution provides is compelling for patients. We are also demonstrating value for doctors and insurers by removing inefficiencies and reducing costs throughout the patient journey.

Regarding its outlook, the company reaffirmed its previously set guidance for FY21, which involves achieving at least 100% organic year-on-year revenue growth. Notably, the revenue growth excludes contributions from its recently acquired Australian business.

Despite these factors, the Doctor Care Anywhere share price is still down 36% over the past year.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

These 13 ASX 200 shares just hit new 52-week highs

These shares had a fine send-off to the weekend this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why AMP, Civmec, Cochlear, and LGI shares are falling today

These shares are ending the week in the red. But why?

Read more »

Three people jumping cheerfully in clear sunny weather.
Share Gainers

These 3 ASX 200 stocks are shooting the lights out this week. Own any?

These ASX 200 shares have soared 11% to almost 23% this week. But why?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Share Gainers

Why GQG, Imugene, Mirvac, and Temple & Webster shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

Shocked office worker staring at computer screen with colleagues working in the background.
Opinions

2 ASX shares with earnings results that shocked me this week

These two results really surprised me.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Leading broker upgrades Pro Medicus shares to buy rating

Analysts at Bell Potter think this tech stock is a top buy right now.

Read more »